New herpes drug shows promise in early safety trial
NCT ID NCT06385327
First seen Nov 21, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This early-stage study tested a new drug called ABI-5366 in 115 people to see if it is safe and how the body processes it. The trial included healthy volunteers and people with recurrent genital herpes caused by HSV-2. The goal was to gather safety data and understand dosing, not to prove the drug works yet.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GENITAL HERPES SIMPLEX TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Canopy Beaches Clinical Research
Sydney, New South Wales, 2100, Australia
-
Canopy Clinical Sutherland
Miranda, New South Wales, 2228, Australia
-
Canopy Clinical Wollongong
Wollongong, New South Wales, 2500, Australia
-
East Sydney Doctors
Darlinghurst, New South Wales, 2010, Australia
-
Momentum Clinical Research
Sydney, New South Wales, 2010, Australia
-
Momentum Kapiti
Waikanae, 5036, New Zealand
-
Momentum Palmerston North
Palmerston North, 4414, New Zealand
-
Momentum Sunshine
Melbourne, Victoria, 3021, Australia
-
New Zealand Clinical Research
Auckland, 1010, New Zealand
-
New Zealand Clinical Research Christchurch
Christchurch, 8011, New Zealand
-
Pacific Clinical Research Network - Hamilton
Hamilton, 3200, New Zealand
-
Pacific Clinical Research Network - Rotorua
Rotorua, 3010, New Zealand
-
Pacific Clinical Research Network - Tasman
Nelson, 7011, New Zealand
-
Pacific Clinical Research Network - Wellington
Upper Hutt, 5018, New Zealand
-
Royal Melbourne Hospital
Parkville, Victoria, 3050, Australia
Conditions
Explore the condition pages connected to this study.